Patient's Query
Hello doctor,
My sister is 41 years old and recently diagnosed with endometrial cancer. Our father had colon cancer at age 52. Her tumor testing showed loss of MLH1 expression, and the doctor mentioned possible Lynch syndrome. Her hemoglobin is 11.8 g/dL, fasting blood sugar is 118 mg/dL, and she has no major symptoms apart from irregular bleeding.
Should she undergo genetic testing to confirm Lynch syndrome?
If positive, what other cancer screenings are required (colon, ovarian, etc.)?
Should other siblings and I also get tested?
How does genetic cancer differ in treatment and prognosis compared to regular cases?
Please help.
Thank you.
Hello,
Welcome to icliniq.com.
I understand your concern.
The loss of MutL homolog 1 (MLH 1) expression in your sister’s tumor, combined with your father’s history of colon cancer at the age of 52, makes further evaluation for Lynch syndrome very important. However, loss of MLH1 expression does not automatically mean that she has Lynch syndrome. In many cases, the loss is caused by a non-inherited change called MLH1 promoter hypermethylation, which is considered sporadic.
The next appropriate step is to determine whether methylation testing was performed on the tumor. If MLH1 promoter hypermethylation is absent, then germline genetic testing should be done to confirm whether she carries a hereditary mutation. If Lynch syndrome is confirmed, enhanced surveillance is essential. This typically includes a colonoscopy every one to two years starting immediately, because the lifetime risk of colorectal cancer is significantly increased.
The risk of ovarian cancer is also elevated, and if she has not already had removal of the ovaries and uterus as part of her cancer treatment, this may be discussed once childbearing is complete. Depending on the specific gene mutation, screening for other cancers such as gastric or urinary tract cancers may also be considered.
If your sister tests positive for a Lynch syndrome mutation, first-degree relatives, including you and other siblings, should undergo genetic counseling and testing, since each sibling would have a fifty percent chance of carrying the same mutation. If you test negative for the identified family mutation, your cancer risk returns to that of the general population.
In terms of treatment and prognosis, Lynch associated tumors are characterized by mismatch repair deficiency, which can influence treatment decisions. These cancers may respond particularly well to immunotherapy if needed. The most important benefit of identifying Lynch syndrome is not only guiding treatment but also preventing future cancers through structured screening and early detection. The next best step is consultation with a genetic counselor to clarify whether this is a hereditary condition and to guide testing and long-term planning for the entire family.
I hope this helps.
Kindly follow up if you have more concerns.
Thank you.
Was this conversation helpful?
Answered byDr. Aissa Youcef Mouffoki
Medically reviewed byiCliniq medical review team
Same symptoms don't mean you have the same problem. Consult a doctor now!
Related Questions
How to preserve fertility in a woman with endometrial cancer?
Can women conceive with early endometrial cancer treatment?
At 37, can I delay endometrial cancer treatment?
At 45, how long has my endometrial cancer been growing?
How can I manage my endometrial cancer recurrence at age 40?
Endometrial Cancer Treatment Options
Endometrial Cancer - Causes, Symptoms, Risk Factors, Stages, Diagnosis, and Treatment
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.